Literature DB >> 15125495

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Law MR, Wald NJ, Rudnicka AR. BMJ 2003; 326: 1407-408.

Sonia S Anand1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15125495     DOI： 10.1191/1358863x03vm518xx

Source DB:  PubMed          Journal:  Vasc Med        ISSN： 1358-863X            Impact factor:   3.239


× No keyword cloud information.
  22 in total

1.  Trends in cardiovascular risk factors among patients with coronary heart disease: results from the EUROASPIRE I, II, and III surveys in the Münster region.

Authors:  Christof Prugger; Jan Heidrich; Jürgen Wellmann; Ralf Dittrich; Stefan-Martin Brand; Ralph Telgmann; Günter Breithardt; Holger Reinecke; Hans Scheld; Peter Kleine-Katthöfer; Peter U Heuschmann; Ulrich Keil
Journal:  Dtsch Arztebl Int       Date:  2012-04-27       Impact factor: 5.594

Review 2.  Lipid lowering with PCSK9 inhibitors.

Authors:  Razvan T Dadu; Christie M Ballantyne
Journal:  Nat Rev Cardiol       Date:  2014-06-24       Impact factor: 32.419

3.  Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells.

Authors:  Tammy A Butterick; Urule Igbavboa; Gunter P Eckert; Grace Y Sun; Gary A Weisman; Walter E Müller; W Gibson Wood
Journal:  Mol Neurobiol       Date:  2010-04-06       Impact factor: 5.590

4.  Sex differences in the effectiveness of statins after myocardial infarction.

Authors:  Igor Karp; Shun-Fu Chen; Louise Pilote
Journal:  CMAJ       Date:  2007-01-30       Impact factor: 8.262

5.  Association between the rs1805081 polymorphism of Niemann-Pick type C1 gene and cardiovascular disease in a sample of an Iranian population.

Authors:  Masoumeh Afzali; Mohammad Hashemi; Seyed Payman Tabatabaei; Kourosh Tirgar Fakheri; Alireza Nakhaee
Journal:  Biomed Rep       Date:  2016-11-07

Review 6.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Mark D Huffman; Ana Filipa Macedo; Theresa H M Moore; Margaret Burke; George Davey Smith; Kirsten Ward; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

7.  Assessing patterns of use of cardio-protective polypill component medicines in Australian women.

Authors:  Jennifer A Stewart Williams; Christopher J Wallick; Julie E Byles; Christopher M Doran
Journal:  Drugs Aging       Date:  2013-03       Impact factor: 3.923

Review 8.  Atorvastatin: its clinical role in cerebrovascular prevention.

Authors:  Achille Gaspardone; Marcello Arca
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes.

Authors:  Scott D Ramsey; Lauren D Clarke; Craig S Roberts; Sean D Sullivan; Scott J Johnson; Larry Z Liu
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  NICE on lipid modification: NICE's simplified approach to lipids will not work.

Authors:  Stuart J Laurie
Journal:  BMJ       Date:  2008-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.